Phytosterols, Ezetimibe, and Cholesterol Metabolism

Completed · Early Phase 1 · Has a placebo group

Conditions studied: Hypercholesterolemia, Coronary Heart Disease

In brief

Phytosterols and ezetimibe each reduce intestinal cholesterol absorption by 30-55% but appear to have different mechanisms of action. The investigators' hypothesis is that phytosterols and ezetimibe given together will block cholesterol absorption in an additive fashion. In a randomized, placebo-controlled crossover trial the effects of placebo, ezetimibe treatment and ezetimibe plus phytosterol treatment will be measured.

Key facts

Study ID
NCT00863265
Run by
Washington University School of Medicine
People needed
22
Starts
2009-06-01
Expected to finish
2010-02-01
Last updated by the study team
2018-06-01

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.